Humacyte Inc expected to post a loss of 16 cents a share - Earnings Preview

Humacyte

08/08/2025 15:46

Humacyte Inc HUMA.OQ HUMA.O is expected to  show a rise in quarterly revenue when it reports  results on August 11 for the period ending June 30 2025

The Durham North Carolina-based  company is expected to report revenue of $1.003 million, according to the mean estimate from 6 analysts, based on LSEG data.

‚ÄčLSEG's mean analyst estimate for Humacyte Inc is for a loss of 16 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ‚Äč

Wall Street's median 12-month price target for Humacyte Inc is $6.50, about 62% above its last closing price of $2.47

Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äč

QUARTER ENDING
STARMINESMARTESTIMATE¬ģ
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.18
-0.19
0.28
Beat
247.4
Dec. 31 2025
-0.27
-0.25
-0.16
Beat
36
Sep. 30 2024
-0.25
-0.25
-0.33
Missed
-32.8‚Äč
Jun. 30 2024
-0.24
-0.24
-0.48
Missed
-101.7
‚Äč‚ÄčMar. 31 2024
-0.22
-0.22
-0.29
Missed
-28.9
Dec. 31 2023
-0.25
-0.24
-0.24
Met
2‚Äč
Sep. 30 2023
-0.25
-0.25
-0.25
Met
1.3
Jun. 30 2023
-0.22
-0.22
-0.22
Met
-0.1

This summary was machine generated August 8 at 14:46 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)